ESCAPE Bio Appoints Edward Owens and Scott Morrison to Board of Directors SOUTH SAN FRANCISCO, Calif. (Business Wire) ESCAPE Bio Inc., a clinical stage company developing novel, precisely targeted therapeutics for genetic neurodegenerative diseases, announced that Edward Owens and Scott Morrison have been appointed to the Board of Directors.
“Ed brings an unparalleled perspective of our industry based on over four decades of outstanding performance investing in healthcare companies,” said Julie Anne Smith, CEO. “We are delighted to have his insight on business fundamentals, industry insights and shareholder value.”
“Scott is a well-respected industry leader who brings over 40 years of financial experience helping life science companies grow from start-up, through initial product launch, to global expansion,” said Tony Rimac, CFO. “We look forward to his financial acumen and corporate insight as we advance our pipeline of Precision Neurology medicines.”